Taylor Schreiber
Patrimonio netto: 19 M $ in data 31/08/2026
Patrimonio netto: 19 M $ in data 31/08/2026
Taylor H.
Schreiber is the founder of Shattuck Labs, Inc., established in 2016, serving as Chief Executive Officer & Director since 2020.
Former jobs include Director at Pelican Therapeutics, Inc. from 2011 to 2017 and Chief Scientific Officer at Scorpius Holdings, Inc. from 2015 to 2016.
Education includes undergraduate studies at Bucknell University and a doctorate from The University of Miami Leonard M.
Miller School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SHATTUCK LABS, INC. 2,72% | 12/05/2026 | 2.732.972 ( 2,72% ) | 19 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SHATTUCK LABS, INC. | Fondatore | 01/01/2016 |
| Società | Posizione | Fine |
|---|---|---|
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Direttore/Membro del Consiglio | 01/01/2017 |
| SCORPIUS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 31/12/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Scorpius Holdings, Inc.
Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Pelican Therapeutics, Inc.
Pelican Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic biological agents for immuno-oncology combinations | Health Technology |
Bucknell University
Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Miami Leonard M. Miller School of Medicine
The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shattuck Labs, Inc.
Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale